Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03243981 · ClinicalTrials.gov registry record · NA
Infrared and Broadband Light for Skin Aging
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03243981: Completed NA study, sponsored by Stanford University.
NCT03243981 is a NA study that has completed, run by Stanford University. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03243981, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
In this exploratory study, we hope to learn if treatment of broadband light with infrared light can alter the molecular pathways associated with aging. Secondary exploratory objective is to see if there are any visible effects of this light treatment on human skin.
Primary Outcome
The endpoint consisted of clinical inspection of biopsies of untreated skin and skin after three treatments. Genes were considered altered if a statistically significant change in transcription of an individual gene was observed between the treated and untreated skin (significance was set at p\<0.01, adjusted for false discovery rate). The values in the table represent the total number of recorded genes with significant change.
Interventions
- DEVICE Sciton SkinTyte (800-1800 nm) with Broadband Light Technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2016-11-20 |
| Est. Completion | 2017-06-20 |
| Phase | NA |
What the finished NCT03243981 record still lists
NCT03243981 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Sciton SkinTyte (800-1800 nm) with Broadband Light Technology is the first listed.
NCT03243981 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03243981 about?
NCT03243981 is a clinical study titled "Infrared and Broadband Light for Skin Aging". In this exploratory study, we hope to learn if treatment of broadband light with infrared light can alter the molecular pathways associated with aging. Secondary exploratory objective is to see if there are any visible effects of this light treatment on human skin.
What is the current status of trial NCT03243981?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2016-11-20. Estimated completion is 2017-06-20.
What interventions are being tested in trial NCT03243981?
The interventions under investigation include: Sciton SkinTyte (800-1800 nm) with Broadband Light Technology (DEVICE).
Who is sponsoring clinical trial NCT03243981?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03243981's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI